Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 10,305

Document Document Title
WO/2009/084743A1
An external preparation containing an active hydrogen-generating agent which generates active hydrogen in the case of bringing a plural number of agents into contact with each other and/or an active hydrogen-generating agent which activa...  
WO/2009/078366A1
Disclosed is a stable α-lipoic acid. Also disclosed is a method for producing α-lipoic acid nanoparticles, which comprises a step of preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; a step of ...  
WO/2009/078474A1
The present invention provides an agent for reducing a side effect of an anticancer drug, which comprises a thrombin-like enzyme.  
WO/2009/076506A3
The present invention concerns the γ-glutamylcysteine treatment to reduce oxidative damage caused by ischemia/reperfusion events such as pulmonary hypertension, transplant, cardiac bypass and other surgeries, and trauma. In specific emb...  
WO/2009/075573A1
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.  
WO/2009/075564A1
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta -galacto -oligosaccharides, fructan, non -digestible alpha -glucan and hemicellulose.  
WO/2009/072004A2
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...  
WO/2009/072004A3
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...  
WO/2009/069736A1
Disclosed is a nitrogenated compound represented by the formula (I) [wherein A represents an aryl which may have a substituent or the like; B's independently represent a hydrogen atom, a halogen or the like; n represents an integer of no...  
WO/2009/068798A1
The invention relates to a composition for protecting and/or preserving cells, tissues and organs, characterised in that it includes at least one modified positively-charged cyclodextrin preferably closely associated with an anti-oxidant...  
WO/2009/064004A1
It has been required to develop a drink which contains citrulline, generates little offensive odor when stored or heated and is easy to drink. Thus, a drink containing citrulline together with citric acid, sodium citrate or disodium hydr...  
WO/2009/055863A1
The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of...  
WO/2009/053637A2
The subject of the present invention is an anti-ricin antibody and the use thereof for the treatment of an individual suffering from ricin poisoning.  
WO/2009/047290A1
A method for the treatment or prevention of a cell or tissue damage in a living subject due to the exposure to ionizing radiation is provided, which comprises administration to said subject of a quaternary pyridinium salt of formula (I) ...  
WO/2009/048120A1
A stable astaxanthin-containing composition which has neither an unpleasant taste nor an unpleasant odor and has a good flavor and improved solubility in aqueous liquids. Also provided is a composition having improved astaxanthin absorba...  
WO/2009/048119A1
It is intended to provide a medicinal composition available as a substitute for FGF2 which contains, as the active ingredient, a chimeric protein comprising an amino acid sequence derived from the amino acid sequence of FGF1 protein by t...  
WO/2009/045655A2
This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In ...  
WO/2009/043176A9
Herbal compositions and their use in the prevention and/or treatment of hepatitis are provided The herbal compositions comprise an extract of flowers, leaves, and roots from the plant genera Cordia, Annona, and Curcuma, respectively, whe...  
WO/2009/043176A1
Herbal compositions and their use in the prevention and/or treatment of hepatitis are provided The herbal compositions comprise an extract of flowers, leaves, and roots from the plant genera Cordia, Annona, and Curcuma, respectively, whe...  
WO/2009/045655A3
This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In ...  
WO/2009/041521A1
An extensive and intensive study was made on an NAD(P)H oxidase inhibitor. As a result, it was confirmed that a quinolone derivative having, at position-2, an alkyl group substituted by a hetero atom or the like had a good NAD(P)H oxidas...  
WO/2009/041640A1
Disclosed is a plant extract which contains an o-diphenol-type chlorogenic acid component at a high concentration. Also disclosed is a plant extract which contains substantially no feruloyl quinic acid component or caffeine component, an...  
WO/2009/041714A1
To provide an external preparation for free radical diseases which is excellent in transdermal and transmucosal absorption properties. An external preparation is obtained by combining 3-methyl-1-phenyl-2-pyrazolin-5-one with a metabolic ...  
WO/2009/036590A1
The present invention relates to novel compounds from Antrodia cinnamomea and their use.  
WO/2009/036574A1
A method of using an estrogen receptor agonist and antagonist to reduce a toxic effect of a cytostatic drug on bone marrow derived cells in a biological system. The methods comprise contacting the cells with a therapeutically effective a...  
WO/2009/027056A2
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/028643A1
Disclosed are: a highly pure, inexpensive and safe composition having a high carotenoid content; a method for the industrial production of the composition; a functional food, a pharmaceutical composition or a cosmetic comprising the comp...  
WO/2009/027056A3
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/027056A4
The present invention relates to novel heparin-nitroxide derivatives comprising heparin and at least two and more nitroxides/polynitroxide radicals that are covalently coupled to heparin by derivatisation of glycosaminoglycan carboxyl or...  
WO/2009/025315A1
Disclosed is a composition for increasing the amount of tetrahydrocurcumin, which is believed to be useful for the maintenance of good health or the amelioration of a disease condition, in a living body efficiently through oral intake. S...  
WO/2009/024957A1
A method of treating or preventing organophosphate exposure associated damage in a subject in need thereof is provided. The method comprising providing the subject with a therapeutically effective amount of the acetylcholinesterase splic...  
WO/2009/025326A1
Disclosed is a method for producing a hydroxytyrosol-containing aqueous olive extract, which comprises a clearing step of contacting an aqueous opaque component with diatomaceous earth, wherein the aqueous opaque component is selected fr...  
WO/2009/023742A9
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/023742A3
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/023742A2
The present invention concerns surface display systems based on conjugates of heterologous molecules to externally exposed spore coat protein sequences. In particular, the invention concerns conjugates, such as fusion proteins, comprisin...  
WO/2009/020192A1
It is intended to provide a composition for oral intake which can effectively prevent skin damage induced by the exposure to ultraviolet light when orally taken. This problem can be solved by a composition for oral intake for preventing ...  
WO/2009/019260A3
The present invention provides compounds and methods for the treatment and prophylaxis of ischemia reperfusion injury. In particular the invention provides compounds which function to suppress Toll-like Receptor 2 biological function or ...  
WO/2009/014702A2
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...  
WO/2009/013596A3
The present invention relates to nutritional products containing hydroxytyrosol, particularly food products (i.e: fortified edible oils and fortified edible oil-containing products) and dietary supplements (i.e.: soft gel capsules contai...  
WO/2009/014702A3
In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount ...  
WO/2009/006773A1
Disclosed is an optically active N- (α-mercaptopropionyl) glycine, that is R-N- (α-mercaptopropionyl) glycine or S-N- (α-mercaptopropionyl) glycine, its preparing method, a pharmaceutical prepn. containing the same compound or its med...  
WO/2009/004842A1
It is intended to develop a technique whereby a vaccine for swine edema disease is produced at a low cost and a high efficiency. More specifically, swine edema disease toxic protein (Stx2e protein) gene is expressed in a plant cell at a ...  
WO/2009/001322A2
The inventors have studied the kinetic and hierarchy of activation of apoptogenic caspases during myocardial ischemia and have found that caspase 2 plays a major role during the cardiac pathology by a very fast activation after an ischem...  
WO/2009/001322A3
The inventors have studied the kinetic and hierarchy of activation of apoptogenic caspases during myocardial ischemia and have found that caspase 2 plays a major role during the cardiac pathology by a very fast activation after an ischem...  
WO/2008/155487A2
The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter...  
WO/2008/157802A1
This invention provides compounds of Formula (I), which are inhibitors of Chk2 and are useful as a radiation protection agents in anticancer radiotherapy. A method of modulating Chk2 in vitro includes treating a substrate with Chk2 in th...  
WO/2008/157393A1
The present invention provides methods of stimulating angiogenesis and the growth or migration of cells associated with angiogenesis, by contacting animals, tissues, or cells with sulfide, alone or in combination with nitric oxide. These...  
WO/2008/153385A1
The invention relates to derivatives of urocanic acid that have improved efficacy and/or tissue penetration properties. The invention further provides use of these derivatives in a medicament for modulating an immune-related disease in a...  
WO/2008/152173A1
This invention concerns phenolic extracts containing procyanidins, propelargonidins and prodelfinidins obtained from peel of the almond [Prunus dulcís (Mili.) D.A. Webb, Prunus amygdalus (L.) Batsch., Amygdalus dulcís (Mili.), Amygdalu...  
WO/2008/149688A1
[PROBLEMS] To provide: a composition having an excellent antioxidative activity; a food or beverage utilizing the composition; and a method for producing the composition. [MEANS FOR SOLVING PROBLEMS] Disclosed are: a composition comprisi...  

Matches 601 - 650 out of 10,305